CME Group SEC Filings

Form 144 notice for CME Group Inc. (CME) shows a proposed sale of 392 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $102,704.00 and an approximate sale date of 09/18/2025 on NASDAQ. The securities were acquired from the issuer as restricted stock on 09/16/2025 and payment was recorded as 09/16/2025. The filing also reports prior transactions: the person for whose account the sale is filed sold 376 shares on 09/16/2025 for gross proceeds of $97,368.96. The filing includes the required representation that the signer does not possess undisclosed material adverse information.

Sunil K. Cutinho, Chief Information Officer of CME Group Inc. (CME), reported share transactions on Form 4 tied to restricted stock vesting. On 09/15/2025 he surrendered 1,117 Class A shares at $258.83 per share to satisfy tax withholding and later received 3,044 shares at the same price, leaving him with 19,367 Class A shares after that trade. On 09/16/2025 he surrendered 379 Class A shares at $259.83 for tax withholding, resulting in 18,988 shares held. The filing is signed on behalf of Mr. Cutinho on 09/17/2025 and lists these transactions as related to vesting and tax obligations.

Julie Winkler, Senior Managing Director and Chief Commercial Officer at CME Group (CME), reported insider transactions related to restricted stock vesting and tax-withholding on September 15-16, 2025. On 09/15/2025 she surrendered 1,081 shares at $258.83 to satisfy tax withholding upon vesting and received 3,044 shares at $258.83 from the vesting event, and on 09/16/2025 she surrendered 379 shares at $259.83 for tax withholding. After these transactions she beneficially owned 25,512 Class A shares. The Form 4 was signed on behalf of Ms. Winkler by Margaret Austin Wright on 09/17/2025. The filing shows routine equity vesting and share-withholding to cover taxes; no derivative transactions or additional compensatory arrangements are disclosed in this Form 4.

Kendal L. Vroman, Chief Transformation Officer of CME Group Inc. (CME), reported insider transactions on a Form 4 showing restricted stock vesting and related tax withholding. On 09/15/2025 he surrendered 971 Class A shares to the company at a reported price of $258.83 to satisfy tax withholding and, on the same day, was recorded as acquiring 2,608 Class A shares at $258.83, bringing his beneficial ownership to 20,395 shares. On 09/16/2025 he surrendered an additional 325 Class A shares at $259.83, leaving 20,070 shares reported as beneficially owned. The form states the surrenders were to fulfill tax withholding obligations upon vesting of restricted stock.

CME Group insider Jonathan L. Marcus reported routine equity transactions in mid-September 2025. On September 15, 2025 he surrendered 259 Class A shares to the company to satisfy tax-withholding obligations related to restricted stock vesting, and on the same day he acquired 2,464 Class A shares at a price of $258.83 per share, leaving him with 8,913 shares beneficially owned. On September 16, 2025 he sold 376 Class A shares at $258.96 under a Rule 10b5-1 plan adopted February 18, 2025, and surrendered an additional 259 shares at $259.83 for tax withholding, resulting in 8,243 shares owned after those transactions. The filing is signed for Mr. Marcus on September 17, 2025.

Suzanne Sprague, COO & Global Head of Clearing of CME Group Inc. (CME), reported stock transactions related to the vesting of restricted shares. On 09/15/2025 she surrendered 639 Class A shares to the company to satisfy tax withholding upon vesting and simultaneously acquired 3,044 Class A shares, leaving her with 11,172 Class A shares after those transactions. On 09/16/2025 she surrendered an additional 325 Class A shares for tax withholding, leaving 10,847 Class A shares reported as beneficially owned.

The Form 4 indicates these transactions were to meet tax obligations tied to restricted stock vesting; no cash purchases or open-market sales are reported and no derivative transactions are disclosed.

Insider transactions at CME Group Inc. (CME)

Lynne Fitzpatrick, President and Chief Financial Officer, reported three Form 4 transactions related to restricted stock vesting on September 15-16, 2025. She surrendered 639 Class A shares on 09/15/2025 and 379 shares on 09/16/2025 to satisfy tax withholding obligations, at prices of $258.83 and $259.83 respectively. On 09/15/2025 she also acquired 4,348 Class A shares at $258.83, reflecting the net issuance from vesting. After these reported transactions, she beneficially owned 20,924 Class A shares directly.

Jack J. Tobin, MD Chief Accounting Officer of CME Group (CME), reported routine equity transactions tied to tax-withholding on vested restricted stock. The filing discloses three non-derivative transactions: on 09/15/2025 Mr. Tobin disposed of 143 shares at $258.83 to satisfy tax withholding and simultaneously acquired 1,546 shares at $258.83, leaving him with 25,142 shares after that activity. On 09/16/2025 he disposed of 57 shares at $259.83 for additional tax withholding, leaving 25,085 shares beneficially owned. The transactions are described as share surrenders to satisfy tax obligations upon vesting of restricted stock.

Michael G. Dennis, Global Head of Fixed Income at CME Group (CME), reported changes to his beneficial ownership in the company. On 09/15/2025 he acquired 2,608 Class A common shares at $258.83 each, bringing his direct holdings to 8,927.3766 shares. On 09/16/2025 he disposed of 289 shares at $259.83, leaving 8,638.3766 direct shares. The filing notes that the shares were surrendered to the company to satisfy tax withholding obligations upon the vesting of restricted stock on 09/16/2025. An additional 40.81 shares are held indirectly by his spouse.